搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
8 小时
ViiV to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...
The Pharma Letter
8 小时
Texas sues firms over alleged insulin price conspiracy
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical companies, including Eli Lilly, and pharmacy ...
The Pharma Letter
9 小时
Judo Bio debuts with $100 million financing
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...
The Pharma Letter
9 小时
Orum prices South Korea listing at $67 million
Orum Therapeutics, specializing in degrader-antibody conjugates, has filed for a $67 million IPO on South Korea's Kosdaq. The ...
The Pharma Letter
9 小时
BRIEF—Orchard and Er-Kim ink Libmeldy distribution deal
Orchard Therapeutics has partnered with Turkish drugmaker Er-Kim for the exclusive distribution of its gene therapy, Libmeldy ...
The Pharma Letter
11 小时
Showing of strength of AstraZeneca’s Airsupra in asthma
AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...
The Pharma Letter
11 小时
ABL Bio inks clinical collaboration with Merck
South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...
The Pharma Letter
15 小时
Pfizer names new UK managing director
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...
The Pharma Letter
13 小时
AstraZeneca boosts cardiovascular pipeline via deal with CSPC
AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical to advance the development of an ...
The Pharma Letter
13 小时
BeiGene enters competitive checkpoint blocker market with Tevimbra
BeiGene has launched Tevimbra (tislelizumab) in the USA for treating adults with esophageal squamous cell carcinoma (ESCC) ...
The Pharma Letter
15 小时
ViroCell Biologics adds former Charles River exec to its team
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...
The Pharma Letter
13 小时
US FDA puts hold on lupus trial after patient deaths
Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈